Programming implantable cardioverter-defibrillators in patients with primary prevention indication to prolong time to first shock: Results from the PROVIDE study

Journal of Cardiovascular Electrophysiology

Volumn 25, Issue 1, 2014, Pages 52-59

  Saeed, Mohammad ^a   Hanna, Ibrahim ^b   Robotis, Dionyssios ^c   Styperek, Robert ^d   Polosajian, Leo ^e   Khan, Ahmed ^f   Alonso, Joseph ^g   Nabutovsky, Yelena ^h   Neason, Curtis ^h  

^a ST LUKE S EPISCOPAL HOSPITAL   (United States)

^b 318 LHRB   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d Department of Pediatric Cardiology   (United States)

^e Cardiac Rhythm Specialists   (United States)

^f Cardiology Consultants   (United States)

^g Central Florida Heart Center   (United States)

^h ST JUDE MEDICAL   (United States)

Author keywords

antitachycardia pacing; implantable cardioverter defibrillator; PROVIDE study; shock reduction; sudden cardiac death; ventricular fibrillation; ventricular tachycardia

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CONTROLLED STUDY; DEFIBRILLATION; FAINTNESS; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART VENTRICLE ARRHYTHMIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT SAFETY; PRIMARY PREVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SUPRAVENTRICULAR TACHYCARDIA; TIME;

ANTITACHYCARDIA PACING; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; PROVIDE STUDY; SHOCK REDUCTION; SUDDEN CARDIAC DEATH; VENTRICULAR FIBRILLATION; VENTRICULAR TACHYCARDIA;

AGED; ARRHYTHMIAS, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PRIMARY PREVENTION; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84891854367     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/jce.12273     Document Type: Article

References (21)

1. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M,: Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996; 335: 1933-1940.
2. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G,: A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 1999; 341: 1882-1890.
3. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML,: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. Multicenter Automatic Defibrillator Implantation Trial II Investigators. N Engl J Med 2002; 346: 877-883.
4. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH,: Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-237.
5. Schron EB, Exner DV, Yao Q, Jenkins LS, Steinberg JS, Cook JR, Kutalek SP, Friedman PL, Bubien RS, Page RL, Powell J,: Quality of life in the antiarrhythmics versus implantable defibrillators trial. Impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation 2002; 105: 589-594.
6. Irvine J, Dorian P, Baker B, O'Brien BJ, Roberts R, Gent M, Newman D, Connolly SJ,: Quality of life in the canadian implantable defibrillator study (CIDS). Am Heart J 2002; 144: 282-289.
7. Carrol D L, Hamilton GA,: Quality of life in implanted cardioverter defibrillator recipients: The impact of a device shock. Heart Lung 2005; 34,: 169-178.
8. Wathen MS, DeGroot PJ, Sweeney MO, Stark AJ, Otterness MF, Adkisson WO, Canby RC, Khalighi K, Machado C, Rubenstein DS, Volosin KJ,: Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. Circulation 2004; 110: 2591-2596.
9. Wilkoff BL, Ousdigian KT, Sterns LD, Wang ZJ, Wilson RD, Morgan JM,: A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: Results from the prospective randomized multicenter EMPIRIC trial. J Am Coll Cardiol 2006; 48: 330-339.
10. Wilkoff BL, Williamson BD, Stern RS, Moore SL, Lu F, Lee SW, Birgersdotter-Gre UM, Wathen MS, Van Gelder IC, Heubner BM, Brown ML, Holloman KK,: Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: Results from the PREPARE (Primary Prevention Parameters Evaluation) study. J Am Coll Cardiol 2008; 52: 541-550.
11. Saeed M, Neason CG, Razavi M, Chandiramani S, Alonso J, Natarajan S, Ip JH, Peress DF, Ramadas S, Massumi A,: Programming antitachycardia pacing for primary prevention in patients with implantable cardioverter defibrillators: Results from the PROVE trial. J Cardiovasc Electrophysiol 2010; 21: 1349-1354.
12. Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP, Estes NAM, Greenberg H, Hall WJ, Huang DT, Kautzner J, Klein H, McNitt S, Olshansky B, Shoda M, Wilber D, Zareba W,: Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med 2012; 13;367: 2275-2283.
13. Boriani G, Occhetta E, Pistis G, Menozzi C, Jorfida M, Sermasi S, Pagani M, Gasparini G, Musso G, Dall'acqua A, Biffi M, Branzi A,: Combined use of morphology discrimination, sudden onset, and stability as discriminating algorithms in single chamber cardioverter defibrillators. Pacing Clin Electrophysiol 2002; 25: 1357-1366.
14. Theuns DA, Rivero-Ayerza M, Goedhart DM, van der Perk R, Jordaens LJ,: Evaluation of morphology discrimination for ventricular tachycardia diagnosis in implantable cardioverter-defibrillators. Heart Rhythm 2006; 3: 1332-1338.
15. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA, 3rd, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Faxon DP, Halperin JL, Hiratzka LF, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura RA, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CW,: ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: Executive summary. Heart Rhythm 2008; 5: 934-955.
16. Saeed M, Razavi M, Neason CG, Petrutiu S,: Rationale and design for programming implantable cardioverter-defibrillators in patients with primary prevention indication to prolong time to first shock (PROVIDE) study. Europace 2011; 13: 1648-1652
17. Collett D: Modelling. Survival Data in Medical Research, 2nd ed. Chapman and Hall, Boca Raton, FL.
18. Kleemann T, Hochadel M, Strauss M, Skarlos A, Seidl K, Zahn R,: Comparison between atrial fibrillation-triggered implantable cardioverter-defibrillator (ICD) shocks and inappropriate shocks caused by lead failure: Different impact on prognosis in clinical practice. J Cardiovasc Electrophysiol 2012; 23: 735-740.
19. Pinski SL, Fahy GJ,: The proarrhythmic potential of implantable cardioverter-defibrillators. Circulation 1995; 92: 1651-1664.
20. Goldenberg I, Moss AJ, Hall WJ, McNitt S, Zareba W, Andrews ML, Cannom DS,: Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the Multicenter Automatic Defibrillator Implantation Trial II. Circulation 2006; 113: 2810-2817.
21. Ruwald AC, Sood N, Ruwald MH, Jons C, Clyne CA, McNitt S, Wang P, Zareba W, Moss AJ,: Frequency of inappropriate therapy in patients implanted with dual- versus single-chamber ICD devices in the ICD arm of MADIT-CRT. J Cardiovasc Electrophysiol 2013; 24: 672-679.